Search

Your search keyword '"Xu, Jianfeng"' showing total 180 results

Search Constraints

Start Over You searched for: Author "Xu, Jianfeng" Remove constraint Author: "Xu, Jianfeng" Publisher wiley Remove constraint Publisher: wiley
180 results on '"Xu, Jianfeng"'

Search Results

1. Characteristics associated with response to subcutaneously administered anti‐CGRP monoclonal antibody medications in a real‐world community cohort of persons living with migraine: A retrospective clinical and genetic study

2. Research Progress in Tunable Metamaterial Absorbers

5. Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry

8. Association of B7‐H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer

9. Association of germline rare pathogenic mutations in guideline‐recommended genes with prostate cancer progression: A meta‐analysis

10. Lack of pharmacokinetic interaction between the HIV‐1 maturation inhibitor GSK3640254 and combination oral contraceptives in healthy women

11. Observed evidence for guideline‐recommended genes in predicting prostate cancer risk from a large population‐based cohort

12. Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients

13. Sarcopenia in Patients With Normal Body Mass Index Is an Independent Predictor for Postoperative Complication and Long‐Term Survival in Gastric Cancer

14. Phase I evaluation of pharmacokinetics and tolerability of the HIV‐1 maturation inhibitor GSK3640254 and dolutegravir in healthy adults

17. Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next‐generation HIV‐1 maturation inhibitor

18. Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progression

19. Validation of a prostate cancer polygenic risk score

21. Dynamic Phosphorylation and Dephosphorylation of CAP1 (Cyclase‐Associated Protein 1) by Antagonistic Signaling through CDK5 and cAMP are Critical for the Protein Functions in Actin Filament Disassembly and Cell Adhesion

24. A missense variant in complement factor B (CFB ) is a potential predictor of 24-week off-treatment response to PegIFNα therapy in Chinese HBeAg-positive chronic hepatitis B patients

25. Two novel genetic variants in the STK38L and RAB27A genes are associated with glioma susceptibility

31. Concept and benchmarks for assessing narrow‐sense validity of genetic risk score values

32. Systematic evaluation of cancer‐specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts

37. Germline mutations in PPFIBP2 are associated with lethal prostate cancer

40. The safety, tolerability, and pharmacokinetic profile of GSK2838232, a novel 2nd generation HIV maturation inhibitor, as assessed in healthy subjects

41. A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer

43. Genetic factors influencing prostate cancer risk in Norwegian men

44. TEX15 : A DNA repair gene associated with prostate cancer risk in Han Chinese

45. Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial

46. Prostate health index significantly reduced unnecessary prostate biopsies in patients with PSA 2-10 ng/mL and PSA >10 ng/mL: Results from a Multicenter Study in China

47. A genetic variant nearGATA3implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS)

49. Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial

50. gsSKAT: Rapid gene set analysis and multiple testing correction for rare‐variant association studies using weighted linear kernels

Catalog

Books, media, physical & digital resources